The beauty of living reference work and Bayesian Adaptive Designs for Phase I trials. Some good news from @DrGWheeler statsci.co.uk/post/principle…

Exciting opportunity for a statistician or data scientist to work with me, Frank Dudbridge, Luke Pilling @timfrayling and many others on developing causal inference methods for multimorbidity research. Apply here tinyurl.com/yf2v7v92 Closing date 30th Aug, please RT!

JOBS | Res Associate (Biostatistician) to work on methodological and computational development for statistical analysis of large, linked electronic health record data F/T funded for 2 yrs closes 10 Sept Paul Lambert Biostatistics: Uni of Leicester jobs.le.ac.uk/vacancies/3265…

NEW PAPER: Want to fairly compare cancer survival outcomes across groups with different other-cause mortality risks? Tired of trying to explain/interpret relative survival and "hypothetical worlds where you can't die of anything but cancer"? Have a read... bmcmedresmethodol.biomedcentral.com/articles/10.11…

My first paper has been published in BMC Diagnostic and Prognostic Research!🥳 Big thanks to co-authors Michael Crowther Michael Sweeting @tmorris_mrc🎉 diagnprognres.biomedcentral.com/articles/10.11…

flexsurv is also now included in the #tidymodels ecosystem through CRAN.R-project.org/package=censor… that is newly on CRAN. Thanks Matt Warkentin for the code in flexsurv that enabled this!

This is Brexit

📢Our paper on estimating causal effects in the presence of competing events is now available open access at rdcu.be/cTCug. We discuss: total, direct and separable effects, and show how to obtain those using regression standardisation with the standsurv command.

We have an exciting opportunity for a #postdoc to join the Oncology Biometrics team at #AstraZeneca in Cambridge, UK. Working with myself at #AstraZeneca and Paul Lambert at #UniversityOfLeicester. Please feel free to DM if you have any questions! careers.astrazeneca.com/job/cambridge/…

Presenting my poster: Exploration of the impact of the treatment mechanism of action on the surrogate relationship between Progression free survival and overall survival in metastatic colorectal cancer, at #ISPOREurope today!

New The British Journal of General Practice paper out from our team! We found that cancer history should be considered as a predictor in future cardiovascular risk scoring tools. Figure below shows that cancer history is linked to raised risks of cardiovascular problems:

Proud to present this work in the BJS academic.oup.com/bjs/advance-ar… thanks to Janet Powell Imperial College London Vascular Surgery Colin Bicknell Michael Sweeting National Institute for Health and Care Research Imperial College London

Missed so much - picture sums her up

if you don't think this is cool, you don't know what cool is #GunsNRoses

I'm delighted to announce publication of a new tutorial article on use of excess hazard models for HTA survival extrapolation with accompanying R and Stata code. Huge thanks to Mark Rutherford Dan Jackson Nick Latimer Paul Lambert and all co-authors doi.org/10.1177/027298…

Hi Cambridgeshire County Council . With the traffic into Cambridge at a standstill most days why do you still insist on charging people over £20 if they park at one of your park and ride sites for more than a day? We don't all come in and out of the city in a day.

Check out our new preprint on an efficient simulation method for comparing dose-finding designs arxiv.org/abs/2402.15460. Thanks to #AstraZeneca co-authors and especially Dr Kristian Brock for implementing in the escalation package with accompanying blog kristianbrock.com/post/comparing…